Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
FEMS Microbiology Letters|May 11, 2006
Escherichia coli TolA tolerates multiple amino-acid substitutions as revealed by screening randomized variants for membrane integrity and phage receptor functionFredrik Karlsson, Ann-Christin Malmborg-Hager, Carl A K BorrebaeckJournal of Bacteriology|April 3, 2003
The mechanism of bacterial infection by filamentous phages involves molecular interactions between TolA and phage protein 3 domainsFredrik Karlsson, Carl A K Borrebaeck, Nina Nilsson, et al.Biotechniques|January 8, 2003
Single framework recombinant antibody fragments designed for protein chip applicationsCornelia Steinhauer, Christer Wingren, Ann-Christin Malmborg Hager, et al.Molecular Immunology|September 11, 2002
In vitro molecular evolution of antibody genes mimicking receptor revisionPeter Ellmark, Olga Esteban, Christina Furebring, et al.Canadian Journal of Microbiology|March 23, 2005
Genome-wide comparison of phage M13-infected vs. uninfected Escherichia coliFredrik Karlsson, Ann-Christin Malmborg-Hager, Ann-Sofie Albrekt, et al.Immunology|August 3, 2002
Modulation of the CD40-CD40 ligand interaction using human anti-CD40 single-chain antibody fragments obtained from the n-CoDeR phage display libraryPeter Ellmark, Camilla Ottosson, Carl A K Borrebaeck, et al.The FEBS Journal|January 31, 2006
Limited mutagenesis increases the stability of human carboxypeptidase U (TAFIa) and demonstrates the importance of CPU stability over proCPU concentration in down-regulating fibrinolysisWolfgang Knecht, Johan Willemse, Hanna Stenhamre, et al.Journal of Immunotoxicology|June 24, 2008
Development of interleukin-1 receptor antagonist mutants with enhanced antagonistic activity in vitro and improved therapeutic efficacy in collagen-induced arthritisEva Dahlén, Karin Barchan, Daniel Herrlander, et al.Proceedings of the National Academy of Sciences of the United States of America|June 14, 2020
Genetic signature of prostate cancer mouse models resistant to optimized hK2 targeted α-particle therapyMesude Bicak, Katharina Lückerath, Teja Kalidindi, et al.Pageof 1